Clinical Trial

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Study acronym: CORE-HCT
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.
Trial Details
NCT Number NCT07349498
Lead Sponsor Peking University People's Hospital
Collaborators: Chinese Academy of Medical Sciences, First Affiliated Hospital of Zhejiang University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Tongji Hospital, Xinqiao hospital of the third military medical university, The First Affiliated Hospital of Zhengzhou University, Sun Yat-Sen University Cancer Center, Sichuan Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital Xi'an Jiaotong University, First Affiliated Hospital of Xinjiang Medical University, Chinese PLA General Hospital, Peking University Shenzhen Hospital, Peking University Third Hospital, Peking University First Hospital
Conditions Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Enrollment 10,000 participants
Start Date 2026-01-01
Primary Completion 2036-06-30 (estimated)
Study Completion 2036-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16